Sue Washer [Photo: Erica Brough/Gainesville Sun]
Applied Genetic Technologies (developer of treatments for a lung disease and diseases that cause blindness)
"Investing in companies is returning to normal after being very depressed in 2009 and early 2010. That makes everyone involved in biotech development very encouraged. The large biotech companies and large multinational pharmaceutical companies are definitely in a mode for licensing, partnerships and acquisitions. They have a great deal of cash on hand."
Claro Scientific (developer of diagnostic systems)